- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05759442
Clinical Efficacy and Safety of Metformin Versus Apple Cider Vinegar (ACV) in Prediabetics (BUHSCK)
August 25, 2023 updated by: Dr. Shizma Junejo, Bahria University
The goal of this clinical trial is to compare efficacy and safety of metformin versus apple cider vinegar in prediabetics . The main question[s] it aims to answer are:
- Efficacy of metformin versus apple cider vinegar in prediabetics
- Safety of metformin versus apple cider vinegar in prediabetics
Researchers will compare group of prediabetics taking metformin with group of prediabetics taking apple cider vinegar to see if there is difference in safety and efficacy..
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
46
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Karachi, Pakistan
- Diabetologist Clinics (02)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Males and Female
- 17-40 years age
- Body Mass index (BMI) overweight and obese
- FBS (100-125 mg/dl)
- HBA1c 5.7% to 6.4%
Exclusion Criteria:
- Concomitant medical problems as established diabetes, hepatic or renal insufficiencies etc.
- Known allergy or intolerance to metformin or apple cider vinegar
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Metformin
Tablet Metformin HCl 500 mg per oral twice daily for 12 weeks
|
Tab Metformin HCL 500mg twice per day aimed at improving glycemic indices in Prediabetics
|
|
Active Comparator: Apple cider vinegar
Apple Cider Vinegar 15ml per day diluted in 200 ml of water for 12 weeks
|
Apple cider vinegar aimed at improving glycemic indices in Prediabetics
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glycated Hemoglobin
Time Frame: 12 weeks
|
Change in glycosylated hemoglobin (HbA1c ) in percent
|
12 weeks
|
|
Fasting Blood Sugar
Time Frame: 12 weeks
|
Change in fasting blood sugar (FBS) in mg/dL
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dr.Shizma Junejo, MBBS,MSc, Bahria University Health Sciences Campus
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Actual)
April 1, 2023
Study Completion (Actual)
July 15, 2023
Study Registration Dates
First Submitted
February 18, 2023
First Submitted That Met QC Criteria
March 6, 2023
First Posted (Actual)
March 8, 2023
Study Record Updates
Last Update Posted (Actual)
August 28, 2023
Last Update Submitted That Met QC Criteria
August 25, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ERC 123/2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PreDiabetes
-
Shifa International HospitalRecruitingPrediabetes | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Prediabetes or DiabetesPakistan
-
Mayo ClinicRecruiting
-
Aga Khan UniversityLinnaeus University; Kenyatta UniversityRecruiting
-
Chonbuk National University HospitalCompletedPreDiabetes
-
National Yang Ming UniversityRecruiting
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Clinical Nutrition Research Centre, SingaporeSingapore Institute for Clinical SciencesCompleted
-
Northwestern UniversityAllianceChicago; Erie Family Health CentersCompleted
-
Ohio UniversityTouro University, CaliforniaCompletedPreDiabetes
Clinical Trials on Metformin Hydrochloride (HCL)
-
Amsterdam UMCZonMw: The Netherlands Organisation for Health Research and DevelopmentNot yet recruitingPre-Eclampsia | HELLP Syndrome | Pre-eclampsia or Eclampsia With Pre-existing Hypertension | HELLP | Pre-Eclampsia; Complicating Pregnancy | Pre-Eclampsia Onset Less Than 37 Weeks | Pre-Eclampsia as Antepartum Condition | Pre-Eclampsia; Affecting Fetus | HELLP Syndrome Complicating Pregnancy
-
Humanis Saglık Anonim SirketiCompletedType 2 Diabetes Mellitus (T2DM)India
-
Humanis Saglık Anonim SirketiCompleted
-
University of California, DavisNational Cancer Institute (NCI); Astellas Pharma Inc; Medivation, Inc.CompletedEnzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate CancerProstate CancerUnited States
-
Laboratorios Silanes S.A. de C.V.Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranUnknown
-
UConn HealthCompletedAging | Vaccine Response Impaired | Age-Related ImmunodeficiencyUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...TerminatedThyroidUnited States
-
National Cancer Institute (NCI)Active, not recruitingHyperplasia | Oral Cavity Carcinoma | Oral Leukoplakia | ErythroplakiaUnited States, Canada
-
Daiichi Sankyo, Inc.TerminatedType 2 Diabetes MellitusUnited States
-
LG Life SciencesUnknown